Julie BORDENAVE

Professionnal Career

2016 - 2020 : Biological Engineer in Jean-Jacques Fournié’s lab , new imunotherapies against lymphomas, CRCT, INSERM, Toulouse, France
2020 - Present : Biological Engineer in team NetB(IO)², CRCT, INSERM, Toulouse, France

Publications

Gava F, Faria C, Gravelle P, Valero JG, Dobaño-López C, Morin R, Norlund M, Gomes A, Lagarde JM, Rossi C, Bordenave J, Pieruccioni L, Rouquette J, Matas-Céspedes A, Fournié JJ, Ysebaert L, Laurent C, Pérez-Galán P, Bezombes C. 3D Model Characterization by 2D and 3D Imaging in t(14;18)-Positive B-NHL: Perspectives for In Vitro Drug Screens in Follicular Lymphoma. Cancers (Basel). 2021 Mar 24;13(7):1490. doi: 10.3390/cancers13071490. PMID: 33804934; PMCID: PMC8036410.

Bordes J, Incerti S, Mora-Ramirez E, Tranel J, Rossi C, Bezombes C, Bordenave J, Bardiès M, Brown R, Bordage MC. Monte Carlo dosimetry of a realistic multicellular model of follicular lymphoma in a context of radioimmunotherapy. Med Phys. 2020 Oct;47(10):5222-5234. doi: 10.1002/mp.14370. Epub 2020 Aug 18. PMID: 32623743.

Decaup E, Rossi C, Gravelle P, Laurent C, Bordenave J, Tosolini M, Tourette A, Perrial E, Dumontet C, Poupot M, Klein C, Savina A, Fournié JJ, Bezombes C. A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma. Front Immunol. 2019 Aug 14;10:1943. doi: 10.3389/fimmu.2019.01943. PMID: 31475004; PMCID: PMC6702952.

Rossi C, Gravelle P, Decaup E, Bordenave J, Poupot M, Tosolini M, Franchini DM, Laurent C, Morin R, Lagarde JM, Ysebaert L, Ligat L, Jean C, Savina A, Klein C, Céspedes AM, Perez-Galan P, Fournié JJ, Bezombes C. Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma. Oncoimmunology. 2018 Dec 17;8(3):1554175. doi: 10.1080/2162402X.2018.1554175. PMID: 30723586; PMCID: PMC6350687.

Rossi, C., Decaup, E., Gravelle, P., Tosolini, M., Franchini, D., Laurent, C., Bordenave, J., Ligat, L., Jean, C., Pont, F., Savina, A., Klein, C., Perez‐Galan, P., Poupot, M., Fournié, J., and Bezombes, C. (2017) PD‐1 IMMUNE CHECKPOINT BLOCKADE IMPROVES ANTI‐CD20 BASED IMMUNOTHERAPY IN FOLLICULAR LYMPHOMA. Hematological Oncology, 35: 257– 258. doi: 10.1002/hon.2438_124.

Research Area
Academic Area
Education

2015 - 2016 : Master 2 in Immunology, University of Aix-Marseille, Marseille, France
2014 - 2015 : Master 1 in Biohealth, University Toulouse III Paul Sabatier, Toulouse, France
2011 - 2014 : Bsc in Cellular biology and physiology, Université Toulouse III Paul Sabatier, Toulouse, France